Terms: = Lymphoma AND PPM1D, Wip1, 8493, ENSG00000170836, O15297, WIP1, PP2C-DELTA AND Prognosis
3 results:
1. The pathophysiological significance of ppm1d and therapeutic targeting of ppm1d-mediated signaling by GSK2830371 in mantle cell lymphoma.
Kojima K; Maeda A; Yoshimura M; Nishida Y; Kimura S
Oncotarget; 2016 Oct; 7(43):69625-69637. PubMed ID: 27626308
[TBL] [Abstract] [Full Text] [Related]
2. Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493).
Frankel LS; Ochs J; Shuster JJ; Dubowy R; Bowman WP; Hockenberry-Eaton M; Borowitz M; Carroll AJ; Steuber CP; Pullen DJ
J Pediatr Hematol Oncol; 1997; 19(1):35-42. PubMed ID: 9065717
[TBL] [Abstract] [Full Text] [Related]
3. [Acute lymphoblastic leukemia in infants--results of treatment according to infant leukemia protocol--POG 8493].
Sońta-Jakimczyk D; Armata J; Bogusławska-Jaworska J; Cyklis R; Chybicka A; Grześkowiak-Melanowska J; Radwańska U; Swiatły A; Wieczorek M
Acta Haematol Pol; 1993; 24(2):131-8. PubMed ID: 8372612
[TBL] [Abstract] [Full Text] [Related]